FOLH1 and neoplasm: Buteau et al. reported a sub-analysis in the TheraP trial and discussed that patients with lower mean 68Ga-PSMA-11 uptake in tumor lesions (PSMA mean) and higher total amount of 18F-FDG uptake in tumor lesions (metabolic tumor volume; MTV) had a lower treatment response [51].